Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis

Seroprevalence of SARS-CoV-2-specific antibodies and vaccination-related adverse events in systemic lupus erythematosus and rheumatoid arthritis

Background: This study aimed to investigate the seroreactivity of Coronavirus disease 2019 (COVID-19) vaccination and its adverse events among systemic lupus erythematosus (SLE) patients, rheumatoid arthritis (RA) patients, and healthy controls (HCs). Methods: A total of 60 SLE patients, 70 RA patie...

Full description

Bibliographic Details
Main Authors: Peng Wang, Jing Ni, Ya-Ya Chu, Qing-Qing Chen, Guo-Cui Wu, Yang Fang, Cong Chen, Ruo-Di Zhang, Ling-Qiong Jiang, Yan Zhao, Xi Fang, Jun He, De-Guang Wang, Gui-Hong Wang, Hai-Feng Pan
Format: Article
Language:English
Published: Elsevier 2022-06-01
Series:Biomedicine & Pharmacotherapy
Subjects:
COVID-19
SARS-CoV-2
Vaccination
SLE
RA
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332222003869

Internet

http://www.sciencedirect.com/science/article/pii/S0753332222003869

Similar Items